Mount Sinai Hospital, New York

• Ji Yoon Yoon

  Lead investigator

• Juan Antonio Requena-Ibáñez

  Lead investigator

Sources: openalex.org

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  Collaborator, Phase 4, Recruiting, 6,000 people, Apr 3, 2025

• NCT06419075

  Collaborator, Phase 4, Withdrawn, 0 people, May 17, 2024

• NCT04258371

  Collaborator, Phase 2, Status unknown, 50 people, Feb 6, 2020

• NCT03842254

  Collaborator, Early phase 1, Completed, 6 people, Feb 15, 2019

• NCT03506724

  Collaborator, Phase 4, Completed, 109 people, Apr 24, 2018

• NCT02754362

  Collaborator, Phase 2, Withdrawn, 0 people, Apr 28, 2016

• NCT02222246

  Collaborator, Phase 4, Completed, 106 people, Aug 21, 2014

• NCT00936858

  Collaborator, Phase 2, Completed, 50 people, Jul 10, 2009

Sources: clinicaltrials.gov

• American Cancer Society

  Targeted Approach to Upper Gastrointestinal Cancer Screening, CSDG-24-1319963-01-ESED, 729K, 2025–2029, Jan 1, 2025

• American Diabetes Association

  Clinical, SOTA-P-CARDIA Clinical Trial., 11-23-PDF-43, 2023–2026, Lead, Nov 15, 2023

Sources: openalex.org

• Outcomes of Mobilisation of Vulnerable Elders in Ontario (MOVE ON): a multisite interrupted time series evaluation of an implementation intervention to increase patient mobilisation

  Jan 1, 2018

Sources: api.crossref.org

• Outcomes following elderly femoral shaft fractures: A GOLD-FEM (geriatric outcomes and long-term data on FEMoral fractures) multicenter study

  American journal of surgery, Oct 30, 2026

• GLP-1 receptor agonist-associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis

  Breast cancer research and treatment, Oct 26, 2026

• Cardiovascular outcomes across GLP-1/GIP agonists in a large, diverse real-world cohort: the INCRETIN-CV study

  ESC Congress 2026 abstract, Oct 26, 2026

• Serial ai based comprehensive coronary physiological assessment before and after intensive lipid lowering therapy: YELLOW III substudy

  ESC Congress 2026 abstract, Oct 26, 2026

• Clinical outcomes and safety of SGLT2 inhibitor therapy in patients with a systemic right ventricle and heart failure: a pre-post analysis from the ACHIEVE-SGLT2i registry

  ESC Congress 2026 abstract, Oct 26, 2026

• Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study

  ESC Congress 2026 abstract, Oct 26, 2026

• Global heart failure cases reached 56 million in 2023

  JAMA cardiology, Oct 1, 2026

• Brain-Wide Multi-Trait Genetic Integration Implicates Lysosomal and Metabolic Axes Linking Visual Disturbance and Alzheimer's Disease

  Molecular neurobiology, Sep 26, 2026

• Metabolite Signatures in Postpartum Prediabetes and Diabetes Among Indian Women With Prior Gestational Diabetes Mellitus: Insights From CHIP-F Study

  Diabetes/metabolism research and reviews, Sep 24, 2026

• Temporal multi-omic analysis uncovers sex-biased molecular programs underlying skeletal muscle adaptation to endurance training

  Cell reports, Aug 12, 2026

• Development of a Cognitive Screen Item Bank: Assessment of Individuals Across the Cognitive Spectrum, Including Advanced Dementia

  Psychological test and assessment modeling, Aug 12, 2026

• The brain and arterial hypertension. Hypertension-mediated vascular damage to the brain and its effects on cognitive and behavioral health

  Revista de la Federación Argentina de Cardiología, Aug 7, 2026

• Sympathetic nervous system activity, tissue iron distribution, and their modulation by empagliflozin in the EMPATROPISM-FE trial

  Research Square, Aug 4, 2026

• Synthesis, Structure, Stability, Efficacy, and Safety of a Therapeutic FSH–Blocking Antibody

  Authorea Preprints, Aug 3, 2026

• Autophagy prevents ER stress-induced Tight Junction barrier disruption via claudin-2 homeostasis

  bioRxiv : the preprint server for biology, Aug 1, 2026

• Tobacco, biological aging and epigenetic resilience: the Andorran paradox

  Frontiers in aging, Jun 11, 2026

• A theoretical model for the influence of age, race and ethnicity on retinal mitochondria dysfunction

  Journal of theoretical biology, May 16, 2026

• C34-24 Thymic Stromal Lymphopoietin (TSLP) Mediates Airway Inflammation and Senescence in Asthma

  American Journal of Respiratory and Critical Care Medicine, May 1, 2026

• B23-04 The Association Between Telomere Length and Prognosis in Interstitial Lung Disease: A Systematic Review and Meta-Analysis

  American Journal of Respiratory and Critical Care Medicine, May 1, 2026

• Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study

  Nature medicine, Mar 31, 2026